Back to Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc.

All insiders

23 insiders

InsiderRole% of sharesShares heldLast trade
ARCH Venture Fund XIII, L.P.10% owner5.82%1,426,528Mar 6, 2026
ARCH Venture Partners IX, LLC10% owner5.82%1,426,528Mar 6, 2026
Seely LynnPresident and CEO · Director0.30%73,878May 11, 2026
Hill Stephen J.Chief Operating Officer0.07%17,795Feb 11, 2026
Lee Gary K.Chief Scientific Officer0.07%16,938Feb 11, 2026
Bulis Veronica SanchezVP, Corporate Controller0.06%15,637Feb 10, 2026
ARCH Venture Fund IX, L.P.10% owner
ARCH Venture Fund IX Overage, L.P.10% owner
ARCH Venture Partners IX, L.P.10% owner
ARCH Venture Partners IX Overage, L.P.10% owner
ARCH Venture Partners XIII, LLC10% owner
ARCH Venture Partners XIII, L.P.10% owner
BERNS PAUL L10% owner
BRAWLEY OTIS WDirectorJun 10, 2026
Burow Kristina10% owner
BYBEE CLINTON10% owner
CRANDELL KEITH10% owner
GILLIS STEVEN10% owner
Meltz Mark AGeneral CounselFeb 10, 2026
NELSEN ROBERT10% owner
RIEFLIN WILLIAM JLDirectorJun 10, 2026
Shah SmitalChief Fin. and Bus. OfficerMar 9, 2026
Shook DavidChief Medical OfficerFeb 10, 2026
← PrevPage 1 of 1Next →